Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Edwards Lifesciences Corp.

This article was originally published in The Gray Sheet

Executive Summary

Baxter Healthcare's CardioVascular Group spin-off is being named after Miles "Lowell" Edwards, the founder of American Edwards Lab, which ultimately was acquired by Baxter in 1985. An electrical engineer by training, Edwards was the co-inventor of the first approved artificial heart valve. The tax-free deal, to be effected in the first six months of 2000, gives Baxter shareholders one share of the new company for each six shares of Baxter held. Edwards Lifesciences will be headquartered in Irvine, California, where the CardioVascular Group is based, and led by Baxter Group VP Michael Mussallem (1"The Gray Sheet" Jan. 10, p. 8)
Advertisement

Related Content

Baxter Web-Enabled Device Development Starting With Renal Dialysis
Baxter Web-Enabled Device Development Starting With Renal Dialysis
Baxter To Sell CVG's Products In Fringe International Markets After Spin-off
Baxter To Sell CVG's Products In Fringe International Markets After Spin-off
Advertisement
UsernamePublicRestriction

Register

MT012848

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel